VEGF-D Recombinant Antibody, RBITC Conjugated
Product Specifications
Background
Growth factor active in angiogenesis, lymphangiogenesis and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. May function in the formation of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Binds and activates VEGFR-2 (KDR/FLK1) and VEGFR-3 (FLT4) receptors.
Synonyms
FIGF; VEGFD.
Gene ID
2277
Swiss Prot
O43915
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Target
VEGF-D
Clonality
Recombinant
Conjugation
RBITC
Source
KLH conjugated synthetic peptide derived from human VEGF D
Applications
WB, IF, Flow-Cyt
Purification
Purified by Protein A.
Excitation Emission
570nm/595nm
Concentration
Lot dependent
Dilution
WB (1:300-5000), IF (), Flow-Cyt (1ug/Test)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
2277
Isotype
IgG
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A1379-37D 25 mg
N- (5-Aminopentyl) -1-naphthalenesulfonamide, Hydrochloride
Sign In for Pricing
View Details